{"id":"https://openalex.org/W2089950832","doi":"https://doi.org/10.1021/mp200460u","title":"The Solubility\u2013Permeability Interplay When Using Cosolvents for Solubilization: Revising the Way We Use Solubility-Enabling Formulations","display_name":"The Solubility\u2013Permeability Interplay When Using Cosolvents for Solubilization: Revising the Way We Use Solubility-Enabling Formulations","alternate_titles":[],"publication_year":2012,"publication_date":"2012-02-22","ids":{"openalex":"https://openalex.org/W2089950832","doi":"https://doi.org/10.1021/mp200460u","mag":"2089950832","pmid":"https://pubmed.ncbi.nlm.nih.gov/22280478"},"language":"en","primary_location":{"id":"doi:10.1021/mp200460u","doi":"https://doi.org/10.1021/mp200460u","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp200460u","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2089950832"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054427131","display_name":"Jonathan M. Miller","orcid":"https://orcid.org/0000-0001-5417-5170","observed_orcids":["https://orcid.org/0000-0001-5417-5170"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan M. Miller","raw_affiliation_strings":["Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, United States","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046452207","display_name":"Avital Beig","orcid":"https://orcid.org/0000-0001-7368-5256","observed_orcids":["https://orcid.org/0000-0001-7368-5256"]},"institutions":[{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Avital Beig","raw_affiliation_strings":["Department of Clinical Pharmacology,\rSchool of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel","Department of Clinical Pharmacology, School of Pharmacy,#R#Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology,\rSchool of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel","institution_ids":["https://openalex.org/I124227911"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy,#R#Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel","institution_ids":["https://openalex.org/I124227911"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert A. Carr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert A. Carr","raw_affiliation_strings":["Global Pharmaceutical\rResearch\rand Development, Abbott Laboratories, Abbott\rPark, Illinois 60064, United States","Global Pharmaceutical#R#Research#R#and Development, Abbott Laboratories, Abbott#R#Park, Illinois 60064, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical\rResearch\rand Development, Abbott Laboratories, Abbott\rPark, Illinois 60064, United States","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"Global Pharmaceutical#R#Research#R#and Development, Abbott Laboratories, Abbott#R#Park, Illinois 60064, United States","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081680395","display_name":"Gregory K. Webster","orcid":"https://orcid.org/0000-0003-3292-5166","observed_orcids":["https://orcid.org/0000-0003-3292-5166"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gregory K. Webster","raw_affiliation_strings":["Global Pharmaceutical\rResearch\rand Development, Abbott Laboratories, Abbott\rPark, Illinois 60064, United States","Global Pharmaceutical#R#Research#R#and Development, Abbott Laboratories, Abbott#R#Park, Illinois 60064, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Pharmaceutical\rResearch\rand Development, Abbott Laboratories, Abbott\rPark, Illinois 60064, United States","institution_ids":["https://openalex.org/I4210088555"]},{"raw_affiliation_string":"Global Pharmaceutical#R#Research#R#and Development, Abbott Laboratories, Abbott#R#Park, Illinois 60064, United States","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029193787","display_name":"Arik Dahan","orcid":"https://orcid.org/0000-0002-3498-3514","observed_orcids":["https://orcid.org/0000-0002-3498-3514"]},"institutions":[{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]}],"countries":["IL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Arik Dahan","raw_affiliation_strings":["Department of Clinical Pharmacology,\rSchool of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel","Department of Clinical Pharmacology, School of Pharmacy,#R#Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology,\rSchool of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel","institution_ids":["https://openalex.org/I124227911"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, School of Pharmacy,#R#Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel","institution_ids":["https://openalex.org/I124227911"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5029193787"],"corresponding_institution_ids":["https://openalex.org/I124227911"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":7.8242,"has_fulltext":false,"cited_by_count":148,"citation_normalized_percentile":{"value":0.98699877,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"9","issue":"3","first_page":"581","last_page":"590"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cosolvents","display_name":"cosolvents","score":0.7319999933242798},{"id":"https://openalex.org/keywords/solubilization","display_name":"solubilization","score":0.8870000243186951},{"id":"https://openalex.org/keywords/intestinal-permeability","display_name":"intestinal permeability","score":0.9020000100135803},{"id":"https://openalex.org/keywords/progesterone","display_name":"progesterone","score":0.921999990940094},{"id":"https://openalex.org/keywords/propylene-glycol","display_name":"propylene glycol","score":0.9480000138282776},{"id":"https://openalex.org/keywords/polyethylene-glycol-400","display_name":"polyethylene glycol 400","score":0.9959999918937683},{"id":"https://openalex.org/keywords/unstirred-layer","display_name":"unstirred layer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/mass-transport-model","display_name":"mass transport model","score":0.8389999866485596},{"id":"https://openalex.org/keywords/oral-absorption","display_name":"oral absorption","score":0.5440000295639038},{"id":"https://openalex.org/keywords/free-fraction","display_name":"free fraction","score":0.4690000116825104},{"id":"https://openalex.org/keywords/lipophilic-drugs","display_name":"lipophilic drugs","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.898836612701416},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8187850713729858},{"id":"https://openalex.org/C120882062","wikidata":"https://www.wikidata.org/wiki/Q28352","display_name":"Permeability (electromagnetism)","level":3,"score":0.628491997718811},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.5782930850982666},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5349921584129333},{"id":"https://openalex.org/C2992270614","wikidata":"https://www.wikidata.org/wiki/Q29548","display_name":"Membrane permeability","level":3,"score":0.44805479049682617},{"id":"https://openalex.org/C4863142","wikidata":"https://www.wikidata.org/wiki/Q907920","display_name":"Solubilization","level":2,"score":0.4421881139278412},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.41761842370033264},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.20151826739311218},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15740403532981873}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002463","descriptor_name":"Cell Membrane Permeability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014783","descriptor_name":"Viscosity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/mp200460u","doi":"https://doi.org/10.1021/mp200460u","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp200460u","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:22280478","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22280478","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.504800021648407,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W173409661","https://openalex.org/W601082420","https://openalex.org/W610950783","https://openalex.org/W1498305210","https://openalex.org/W1515081594","https://openalex.org/W1545435796","https://openalex.org/W1966960575","https://openalex.org/W1982285050","https://openalex.org/W2003650273","https://openalex.org/W2007217346","https://openalex.org/W2007327214","https://openalex.org/W2014467650","https://openalex.org/W2014711692","https://openalex.org/W2031930233","https://openalex.org/W2032395580","https://openalex.org/W2034271371","https://openalex.org/W2036442936","https://openalex.org/W2039099865","https://openalex.org/W2044578448","https://openalex.org/W2045015004","https://openalex.org/W2047912169","https://openalex.org/W2054666684","https://openalex.org/W2061742628","https://openalex.org/W2065371215","https://openalex.org/W2066847123","https://openalex.org/W2069235788","https://openalex.org/W2070845341","https://openalex.org/W2072922667","https://openalex.org/W2079495578","https://openalex.org/W2090727186","https://openalex.org/W2094323693","https://openalex.org/W2097275187","https://openalex.org/W2098027131","https://openalex.org/W2101171473","https://openalex.org/W2102182534","https://openalex.org/W2107196556","https://openalex.org/W2110278176","https://openalex.org/W2111505323","https://openalex.org/W2112352678","https://openalex.org/W2112722416","https://openalex.org/W2119790258","https://openalex.org/W2124278256","https://openalex.org/W2134441665","https://openalex.org/W2135732933","https://openalex.org/W2135870777","https://openalex.org/W2154889565","https://openalex.org/W2155451228","https://openalex.org/W2159728014","https://openalex.org/W2416062726","https://openalex.org/W4295813351"],"related_works":["https://openalex.org/W2036442936","https://openalex.org/W2159728014","https://openalex.org/W2032395580","https://openalex.org/W2044578448","https://openalex.org/W1964245308","https://openalex.org/W2762346084","https://openalex.org/W2343507912","https://openalex.org/W2765656332","https://openalex.org/W2030128944","https://openalex.org/W2071635244"],"abstract_inverted_index":{"We":[0],"have":[1],"recently":[2],"reported":[3],"the":[4,15,18,32,47,62,73,89,101,145,150,167,172,177,186,197,213,222,240,274,291,299],"interplay":[5],"between":[6,17,273],"apparent":[7,79,214,275],"aqueous":[8,80],"solubility":[9,81,276],"and":[10,23,83,105,149,176,236,245,277],"intestinal":[11,85],"membrane":[12,173,248],"permeability,":[13,278],"showing":[14],"trade-off":[16,271],"two":[19],"when":[20,285],"using":[21,66],"cyclodextrin-":[22],"surfactant-based":[24],"systems":[25,96],"as":[26,260],"solubility-enabling":[27,287],"formulations.":[28],"In":[29],"these":[30,51],"cases,":[31],"decreased":[33,40,114],"permeability":[34,86,124,174,182,227],"could":[35],"be":[36,281],"attributed":[37],"directly":[38],"to":[39,46,60,160,184,289,297],"free":[41,115,153],"fraction":[42],"of":[43,56,88,100,152,169,258,263],"drug":[44,91],"due":[45],"complexation/micellization":[48],"inherent":[49],"in":[50,68,95,122,134,295],"solubilization":[52,109,170],"methods.":[53],"The":[54,78,164,192,252],"purpose":[55],"this":[57,108,162],"study":[58],"was":[59,119,142,158],"investigate":[61],"direct":[63,270],"solubility-permeability":[64,293],"interplay,":[65],"formulations":[67,288],"which":[69,279],"complexation":[70],"is":[71,242],"not":[72,112],"mechanism":[74],"for":[75,226],"increased":[76,131,140],"solubilization.":[77],"(S(aq))":[82],"rat":[84],"(P(eff))":[87],"lipophilic":[90],"progesterone":[92,132],"were":[93],"measured":[94],"containing":[97],"various":[98],"levels":[99],"cosolvents":[102,130],"propylene":[103],"glycol":[104],"PEG-400,":[106],"since":[107,234],"method":[110],"does":[111],"involve":[113],"fraction.":[116,154],"Thermodynamic":[117],"activity":[118],"maintained":[120],"equivalent":[121],"all":[123],"studies":[125],"(75%":[126],"equilibrium":[127],"solubility).":[128],"Both":[129],"S(aq)":[133,141],"nonlinear":[135],"fashion.":[136],"Decreased":[137],"P(eff)":[138,188,246,259],"with":[139,203,210,218,231,238,250],"observed,":[143],"despite":[144],"constant":[146],"thermodynamic":[147,223],"activity,":[148],"nonrelevance":[151],"A":[155],"mass-transport":[156],"analysis":[157,193],"developed":[159],"describe":[161],"interplay.":[163],"model":[165,253],"considers":[166],"effects":[168],"on":[171,190],"(P(m))":[175],"unstirred":[178],"water":[179],"layer":[180],"(UWL)":[181],"(P(aq)),":[183],"predict":[185],"overall":[187,300],"dependence":[189],"S(aq).":[191,264],"revealed":[194],"that":[195,206,229,268],"(1)":[196],"effective":[198],"UWL":[199,241],"thickness":[200],"quickly":[201],"decreases":[202,217],"\u2191S(aq),":[204,219,239],"such":[205,228],"P(aq)":[207],"markedly":[208],"increases":[209],"\u2191S(aq);":[211,232],"(2)":[212],"membrane/aqueous":[215],"partitioning":[216],"thereby":[220],"reducing":[221],"driving":[224],"force":[225],"\u2193P(m)":[230,237],"(3)":[233],"\u2191P(aq)":[235],"shorted":[243],"out":[244],"becomes":[247],"control":[249],"\u2191S(aq).":[251],"enabled":[254],"excellent":[255],"quantitative":[256],"prediction":[257],"a":[261,269],"function":[262],"This":[265],"work":[266],"demonstrates":[267],"exists":[272],"must":[280],"taken":[282],"into":[283],"account":[284],"developing":[286],"strike":[290],"optimal":[292],"balance,":[294],"order":[296],"maximize":[298],"oral":[301],"absorption.":[302]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2089950832","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
